MFDS — authorised 22 October 2020
- Marketing authorisation holder: GILEAD SCIENCES INC
- Status: likely_approved
MFDS authorised Veklury on 22 October 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 22 October 2020.
GILEAD SCIENCES INC holds the South Korean marketing authorisation.